1,380
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain

, , , , , & show all
Pages 227-235 | Received 27 Oct 2023, Accepted 15 Dec 2023, Published online: 25 Dec 2023